Hosted on MSN
Positive proof-of-concept experiments may lead to the world's first treatment for celiac disease
An investigational treatment for celiac disease effectively controls the condition—at least in an animal model—in a first-of-its-kind therapeutic for a condition that affects approximately 70 million ...
Health on MSN
How Is Celiac Disease Treated?
The main treatment for celiac disease is a strict gluten-free diet. Be careful of medications with gluten, which can worsen ...
The Gluten3S research group launched a dietary intervention with children who had recently been diagnosed with celiac disease ...
Massachusetts lawmakers have introduced two bills aimed at addressing long-standing gaps in the diagnosis of celiac disease and improving access to safe, gluten-free meals for children participating ...
Celiac disease frustratingly restrictive, the only real medical intervention for sufferers being to avoid gluten altogether. What's more, diagnosis is arduous and involves consuming gluten to ...
ImmusanT, a biotechnology company, raised $20 million in funding from Vatera Healthcare Partners, a venture capital firm focusing on biopharmaceutical firms, for the development of a vaccine and ...
On the heels of new federal funding for its breakthrough immunology platform, Evoq Therapeutics has signed a global license agreement with biopharma giant Sanofi that could land the Chicago-based ...
FDA grants Fast Track designation to Teva's TEV-53408, an anti-IL-15 antibody for celiac disease in Phase 2a study. Teva Pharmaceutical Industries has received Fast Track designation from the FDA for ...
The MarketWatch News Department was not involved in the creation of this content. The growing comprehension of the pathogenesis of celiac disease has paved the way for the exploration of alternative ...
A celiac disease diagnosis can feel daunting and confusing as you learn to navigate the condition. Nutrition experts weigh in on the seven things you should do first once you’ve been diagnosed.
CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results